SEARCH

SEARCH BY CITATION

REFERENCES

  • Armstrong F, Duplantier MM, Trempat P, Hieblot C, Lamant L, Espinos E, Racaud-Sultan C, Allouche M, Campo E, Delsol G, Touriol C. 2004. Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells. Oncogene 23:60716082.
  • Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, Morris SW. 2001. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 159:411415.
  • Bueno C, Almeida J, Lucio P, Marco J, Garcia R, de Pablos JM, Parreira A, Ramos F, Ruiz-Cabello F, Suarez-Vilela D, San Miguel JF, Orfao A. 2004. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica 89:5869.
  • Chang TY, Jaffray J, Woda B, Newburger PE, Usmani GN. 2011. Hemophagocytic lymphohistiocytosis with MUNC13-4 gene mutation or reduced natural killer cell function prior to onset of childhood leukemia. Pediatr Blood Cancer 56:856858.
  • Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto J-J, Bensa J-C, Brière F, Plumas J, Jacob M-C. 2001. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 97:32103217.
  • Chen J, Zhou J, Qin D, Xu S, Yan X. 2011. Blastic Plasmacytoid Dendritic Cell Neoplasm. J Clin Oncol 29:e27e29.
  • Chikatsu N, Kojima H, Suzukawa K, Shinagawa A, Nagasawa T, Ozawa H, Yamashita Y, Mori N. 2003. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol 16:828832.
  • Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, De Wolf-Peeters C, Pauwels P, Hagemeijer A, Marynen P. 2002. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 34:354362.
  • De Paepe P, Baens M, van Krieken H, Verhasselt B, Stul M, Simons A, Poppe B, Laureys G, Brons P, Vandenberghe P, Speleman F, Praet M, De Wolf-Peeters C, Marynen P, Wlodarska I. 2003. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 102:26382641.
  • Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP. 2007. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 109:17201727.
  • Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drenou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Bene MC. 2002. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 99:15561563.
  • Filipovich AH. 2009. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 127131.
  • Garnache-Ottou F, Feuillard J, Saas P. 2007. Plasmacytoid dendritic cell leukaemia/lymphoma: Towards a well defined entity? Br J Haematol 136:539548.
  • Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadie M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V, Macintyre E, Bene MC, Saas P, Jacob MC. 2009. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 145:624636.
  • Gascoyne RD, Lamant L, Martin-Subero JI, Lestou VS, Harris NL, Muller-Hermelink HK, Seymour JF, Campbell LJ, Horsman DE, Auvigne I, Espinos E, Siebert R, Delsol G. 2003. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: Report of 6 cases. Blood 102:25682573.
  • Gilliland DG. 2002. Molecular genetics of human leukemias: New insights into therapy. Semin Hematol 39:611.
  • Greaves MF, Wiemels J. 2003. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3:639649.
  • Hu SC-S, Tsai K-B, Chen G-S, Chen P-H. 2007. Infantile CD4+/CD56+ hematodermic neoplasm. Haematologica 92:e91e93.
  • Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K, Kawa K. 2007. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86:5865.
  • Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Bene MC, Bensa JC, Briere F, Plumas J. 2003. CD4+ CD56+ lineage negative malignancies: A new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 88:941955.
  • Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES. 2010. Blastic plasmacytoid dendritic cell neoplasm in children: Diagnostic features and clinical implications. Haematologica 95:18731879.
  • Juco J, Holden JT, Mann KP, Kelley LG, Li S. 2003. Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. Am J Clin Pathol 119:205212.
  • Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dereure O, Wetterwald M, d'Incan M, Grange F, Cornillon J, Tertian G, Maubec E, Saiag P, Barete S, Templier I, Dalle S. 2013. Blastic plasmacytoid dentritic cell neoplasm:Clinical features in 90 patients. Br J Dermatol 169:579586.
  • Kesler MV, Paranjape GS, Asplund SL, McKenna RW, Jamal S, Kroft SH. 2007. Anaplastic large cell lymphoma: A flow cytometric analysis of 29 cases. Am J Clin Pathol 128:314322.
  • Kumar M, Boggino H, Hudnall SD, Velagaleti GV. 2000. Acute myeloid leukemia associated with hemophagocytic syndrome and t(4;7)(q21;q36). Cancer Genet Cytogenet 122:2629.
  • Laurent C, Do C, Gascoyne RD, Lamant L, Ysebaert L, Laurent G, Delsol G, Brousset P. 2009. Anaplastic lymphoma kinase–positive diffuse large b-cell lymphoma: A rare clinicopathologic entity with poor prognosis. J Clin Oncol 27:42114216.
  • Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, Le Mée F, Plessis G, Talmant P, Gachard N, Uettwiller F, Pages M-P, Mozziconacci M-J, Eclache V, Sibille C, Avet-Loiseau H, Lafage-Pochitaloff M. 2002. CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: A study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood 99:41544159.
  • Leung R, Chow EE, Au W-Y, Chow C, Kwong Y-L, Lin S-Y, Ma ES, Wan TS, Wong K-F. 2006. CD4+/CD56+ hematologic malignancy with rearranged MLL gene. Hum Pathol 37:247249.
  • Lucioni M, Novara F, Fiandrino G, Riboni R, Fanoni D, Arra M, Venegoni L, Nicola M, Dallera E, Arcaini L, Onida F, Vezzoli P, Travaglino E, Boveri E, Zuffardi O, Paulli M, Berti E. 2011. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood 118:45914594.
  • Muench MO, Roncarolo MG, Namikawa R. 1997. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood 89:13641375.
  • Ng A, Lade S, Rutherford T, McCormack C, Prince H, Westerman D. 2006. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): A report of five cases. Haematologica 91:143144.
  • Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA. 2005. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): A review. Am J Clin Pathol 123:662675.
  • Reimer P, Rudiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, Konrad Muller-Hermelink H, Wilhelm M. 2003. What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant 32:637646.
  • Swerdlow SH. 2008. WHO Classification of Tumors Of Hematopoietic And Lymphoid Tissues, 4 ed. Lyon: International Agency for Research on Cancer.
  • Tadmor T, Vadazs Z, Dar H, Laor R, Attias D. 2006. Hemophagocytic syndrome preceding acute myeloid leukemia with der t[7:17][q12;q11], monosomy, 17 and 5p. J Pediatr Hematol Oncol 28:544546.
  • Touriol C, Greenland C, Lamant L, Pulford K, Bernard F, Rousset T, Mason DY, Delsol G. 2000. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 Cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 95:32043207.
  • Toya T, Nishimoto N, Koya J, Nakagawa M, Nakamura F, Kandabashi K, Yamamoto G, Nannya Y, Ichikawa M, Kurokawa M. 2012. The first case of blastic plasmacytoid dendritic cell neoplasm with MLL-ENL rearrangement. Leuk Res 36:117118.
  • Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD. 2009. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937951.
  • Wang WY, Gu L, Liu WP, Li GD, Liu HJ, Ma ZG. 2011. ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript. Pathol Res Pract 207:587591.
  • Wright D, McKeever P, Carter R. 1997. Childhood non-Hodgkin lymphomas in the United Kingdom: Findings from the UK Children's Cancer Study Group. J Clin Pathol 50:128134.